Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...